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Lacrimal glandPax6 is an essential transcription factor for lens, lacrimal gland and pancreas development. Previous trans-
genic analyses have identiﬁed several Pax6 regulatory elements, but their functional signiﬁcance and binding
factors remain largely unknown. In this study, we generated two genomic truncations to delete three ele-
ments that were previously shown to bind to the Meis/Prep family homeoproteins. One 3.1 kb deletion
(Pax6ΔDP/ΔDP) removed two putative pancreatic enhancers and a previously identiﬁed ectodermal enhancer,
while a 450 bp sub-deletion (Pax6ΔPE/ΔPE) eliminated only the promoter-proximal pancreatic enhancer. Im-
munohistochemistry and quantitative RT-PCR showed that the Pax6ΔPE/ΔPE pancreata had a signiﬁcant de-
crease in Pax6, glucagon, and insulin expression, while no further reductions were observed in the Pax6ΔDP/
ΔDP mice, indicating that only the 450 bp region is required for pancreatic development. In contrast,
Pax6ΔDP/ΔDP, but not Pax6ΔPE/ΔPE mice, developed stunted lacrimal gland and lens hypoplasia which was sig-
niﬁcantly more severe than that reported when only the ectodermal enhancer was deleted. This result sug-
gested that the ectodermal enhancer must cooperate with its neighboring sequences to regulate the Pax6
ectodermal expression. Finally, we generated conditional knockouts of Prep1 in the lens and pancreas, but
surprisingly, did not observe any developmental defects. Together, these results provide functional evidence
for the independent and synergistic roles of the Pax6 upstream enhancers, and they suggest the potential re-
dundancy of Meis/Prep protein in Pax6 regulation.
© 2012 Elsevier Inc. All rights reserved.Introduction
Pax6 is an evolutionarily conserved transcription factor critical for
embryogenesis. By E9.5 during murine eye development, Pax6 is
expressed in both the optic cup, which will form the neural retina,
and a portion of the head surface ectoderm, which will eventually in-
vaginate to form the lens. Pax6-null mice cannot form these eye struc-
tures, nor the proper nasal structures to sustain breathing, and die at
birth (Grindley et al., 1995). Furthermore, humans heterozygous for
PAX6 develop blindness, aniridia (iris hypoplasia), Peter's anomaly
(lens–cornea attachment), colobomas, glaucoma and cataracts,
while reduced expression of Pax6 in mice lead to microphthalmia
and numerous defects in the anterior chamber of the eye (Glaser et
al., 1994; Hill et al., 1991; Hogan et al., 1986; Kokotas and Petersen,
2010). This evidence demonstrates that eye development requires a
precise level of Pax6 expressed in an exact spatiotemporal manner.
Pax6 is also expressed as early as E8.5 in the early murine pancre-
atic bud, but later becomes restricted to the four islet endocrine cell
types (α, β, δ and ε) that make up the Islets of Langerhans whichdelphia, PA, USA.
rights reserved.secrete insulin and glucagon. The promoter regions of the genes
encoding glucagon, insulin and somatostatin all contain Pax6 binding
sites, and Pax6 has been shown to actively regulate these genes in cell
culture (Andersen et al., 1999; Ritz-Laser et al., 1999; Sander et al.,
1997). Consistent with this, the Pax6-null mutants lack the
glucagon-producing alpha cells, and the remaining endocrine cells
form disorganized islets intermixed with exocrine cells (St-Onge et
al., 1997). In addition, conditional inactivation of Pax6 in islet cells
causes mutants to die several days after birth as a result of an overt
diabetic phenotype, indicating a crucial role for Pax6 in β cell function
(Ashery-Padan et al., 2004). In humans, glucose intolerance and dia-
betes have also been observed in patients with PAX6 heterozygous
mutations, further underscoring the exquisite sensitivity of human
physiology to PAX6 dosage (Yasuda et al., 2002).
The intricate spatiotemporal expression pattern of Pax6 is con-
trolled by a complex array of regulatory enhancer regions. A well
characterized cis-regulatory region located at 3.9 kb upstream to the
murine Pax6 P0 promoter, termed the ectodermal enhancer (EE),
has been shown to direct lens-speciﬁc expression in transgenic mice
(Kammandel et al., 1999; Williams et al., 1998; Zhang et al., 2002).
The functional signiﬁcance of this 341 bp enhancer element was fur-
ther demonstrated by target deletion in the mouse genome, which
led to diminished Pax6 expression and lens hypoplasia (Dimanlig et
al., 2001). Nevertheless, signiﬁcant Pax6 expression persisted in this
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lens speciﬁc enhancer(s). We have also previously identiﬁed at 1.9 kb
upstream of the Pax6 P0 promoter a 450 bp sequence that is con-
served from human, mouse to fugu ﬁsh (Zhang et al., 2003, 2006).
This more promoter proximal enhancer, hereafter referred as PE,
can drive islet-speciﬁc expression as shown by transient transgenic
analysis. However, Kammandel et al. (1999) have instead localized
the Pax6 pancreatic enhancer in a 1.1 kb distal element (hereafter re-
ferred as DE) at 4.6 kb upstream from the Pax6 P0 promoter. In fur-
ther confusion, the Pax6 pancreatic expression was reported to be
replicated by a 160 kb murine BAC-GFP transgene carrying the two
putative Pax6 pancreatic enhancers (PE and DE), but not by a
420 kb YAC-GFP reporter that carries the homologous human se-
quences (Kim and Lauderdale, 2006; Kleinjan et al., 2006). Therefore,
extensive transgenic studies have thus far failed to resolve the identi-
ty of the mammalian Pax6 pancreatic enhancer(s).
Little is known about the upstream transcription factors that di-
rectly control the Pax6 expression. Combining biochemical and trans-
genic analysis, we have ﬁrst showed that the closely related Meis1
and Meis2 can bind to the Pax6 EE sequence to regulate lens expres-
sion (Zhang et al., 2002). Extending this ﬁnding further, we next ob-
served that the Pax6 PE sequence contains a composite site for Meis
and Pbx homeoprotein binding, which is necessary for the Pax6 pan-
creatic enhancer activity in mouse (Zhang et al., 2006). Interestingly,
biochemical studies showed that this site binds relatively weakly to
Meis1 and Meis2, but more strongly to the more distantly related
Prep1 (pknox1) and Prep2 (pknox2), which belongs to the same
TALE class homeodomain transcription factors. This has been con-
ﬁrmed in studies of the zebraﬁsh pax6b gene, where the correspond-
ing PE and DE sequences were also found to bind the Prep/Pbx
complex in vitro (Delporte et al., 2008). More recently, Rowan et al.
showed that the systemic inactivation of Prep1 disrupts Pax6 expres-
sion and lens formation (Rowan et al., 2010). Taken together, these
studies suggest that Prep1 binds to multiple upstream enhancers to
regulate Pax6 expression in both lens and pancreatic development.
In our present study, weﬁrst tested thismodel of a conservedmech-
anism of Pax6 regulation byMeis/Prep by generating a series of Pax6 en-
hancer knockout mice. We showed that deletion of the 450 bp Pax6 PE
sequence signiﬁcantly reduced pancreatic Pax6 expression and the
number of endocrine cells. In contrast, a larger 3.1 kb deletion encom-
passing the Pax6 PE, DE and EE elements did not further diminish
Pax6 expression in the pancreas, but led to more severe lens defects
than previously observed by deleting the EE enhancer alone. This sug-
gests that the Pax6 PE sequence plays a critical role in promoting the
Pax6 pancreatic expression, while the Pax6 lens expression is controlled
by both the EE element and its surrounding sequences. Finally, we gen-
erated a conditional knockout of Prep1 in the lens and the pancreas, but
the resultingmutant did not exhibit any Pax6 expression changes or de-
velopmental defects. These results thus reveal the complexity and re-
dundancy of Pax6 transcriptional regulation.
Materials and methods
Generation of the Pax6 enhancer knockout mice
The Pax6 enhancer targeting vector was generated using the recom-
bineering method (Fig. 1A) (Liu et al., 2003). In brief, a 12.3 kb Pax6 ge-
nomic sequence containing the 1.1 kb distal enhancer element (DE),
the ectodermal enhancer element (EE) and the 450 bp proximal en-
hancer element (PE) was ﬁrst cloned from a 129S6/SvEvTac BAC clone
(BACPAC Resources Center at Children's Hospital Oakland Research In-
stitute, catalog number RP22-55A14) by gap repair into pPL253, a
MC1TK-containing plasmid. Through homologous recombination, a
loxP site and a Sph I site was inserted next to the Spe I site upstream
to DE sequence, whereas the 450 bp PE sequence was replaced by an
frt-ﬂankedNeo selection cassette. The resulting Pax6 enhancer targetingvector was veriﬁed by direct sequencing and linearized to transfect ES
cells (129S6/SvEvTac) by electroporation. After drug selection, the pos-
itive ES cell cloneswere further screened by Southern blot using both 5′
(Sph I) and 3′ (Spe I) external probes and injected into C57BL/6 mouse
blastocysts to generate Pax6Neo mice. Tail biopsies were then collected
and genotype-PCR performed to conﬁrm the correct targeting (primers
for Neo insert: Pax6Neo F: 5′-GAAGGGACTGGCTGC TATTG-3′ and
Pax6Neo R: AATATCACGGGTAGCCAACG-3′; primers for the wild type
allele: Pax6+ F: 5′-CGCCGAATTCAGTGTGGCCTAGAGACGCTG-3′ and
Pax6+ R: CCAGCTTATCTATCTGTCTGTCAATAAAGGGC-3′). The
Pax6Neo/+ mice were next crossed to the FLP-recombinase mice (stock
number 009086, Jackson Laboratory, Bar Harbor, ME) to remove the
frt-ﬂanked Neo cassette in the germline. The resulting Pax6ΔPE/+ mice
were then conﬁrmed by genotype-PCR (primers: Pax6ΔPE F: 5′-
CAAAAGCTTGGAAAGGACGCTCCAGCA TCCCAG-3′ and Pax6ΔPE R: 5′-
ATAAGCGGC CGCGAATCCTGAGAGTTTGGGTA GTG-3′). The Pax6ΔDP
mice were generated by crossing the Pax6ΔPE/+ mice with the EIIa-Cre
mice (stock number #003724, Jackson Laboratory, Bar Harbor, ME) to
further remove both the DE and EE enhancer elements in the
germline, and conﬁrmed by both Southern blots and genotype-PCR
(Pax6ΔDP F: 5′-AAAGTGGTGGAC AAGATTGC-3′ and Pax6ΔDP R: 5′-
TTAGGGACAGAG CCCTCAGA-3′).
The Pax6Neo, the Pax6ΔPE and the Pax6ΔDP mice were back crossed
six generations into C57BL/6 background. The presence of a vaginal
plug was considered 0.5 days post coitum, or E0.5. All experimental
procedures involving mice were humanely performed in accordance
with the Laboratory Animal Research Center at Indiana University
(LARC).
Generation of the Prep1ﬂox mice
For the construction of the Prep1ﬂox targeting vector, a 9.2 kb se-
quence containing the Prep1 genomic region was retrieved from a
BAC clone (BACPAC Resources Center at Children's Hospital Oakland
Research Institute, catalog number RPCI23-2k17) by gap repair into
pPL253. This plasmid was further modiﬁed with the recombineering
method to insert two loxP sites and an frt-ﬂankedNeo selection cassette
next to the Prep1 exon 8 sequences. Two new restriction sites, EcoR V
and Kpn I, were also added to allow the Southern blot identiﬁcation of
correctly targeted ES cell clones, which were used to generate the Pre-
p1Neo mice. The Neo cassette was subsequently removed by mating
the Prep1Neo mice with the FLPmice, which left only the two loxP sites
ﬂanking the Prep1 exon 9 sequences in the Prep1ﬂox mice. To validate
that the exon 8 can be cleaved via Cre-mediated recombination, the Pre-
p1ﬂox mice were also crossed with the EIIa-Cre strain to generate the
Prep1Δmice, which were used in Western blot and genotype-PCR con-
ﬁrmation (primers: Prep1f F: 5′-ACAGGAGAAGCAGGCAAAGA-3′ and
Prep1f R: 5′-CTGTCCATCACTCCCTGTCC-3′; Prep1Δ F: 5′-AGCTGCTT-
CAGGGCTGTCT-3′). The Prep1ﬂox mice were back crossed six genera-
tions into C57BL/6 background before mated with the Le-Cre (kindly
provided by Dr. Ruth Ashery-Padan, Tel Aviv University, Tel Aviv, Israel
and Dr. Richard Lang, Children's Hospital Research Foundation, Cincin-
nati, OH) and Ap2α-Cre (kindly provided byDr. AnnMoon, University of
Utah, Salt Lake City, UT) to ablate Prep1 in the lens and the pancreas.
Quantitative real time RT-PCR
E15.5 pancreata were quickly collected from litters of Pax6ΔPE/+×
Pax6ΔPE/+ and Pax6ΔDP+×Pax6ΔDP/+matings in ice cold DEPC-treated
PBS, before placed in 100 μl of ice cold RNAlater™ (SIGMA) and brief-
ly chopped into ﬁne pieces while kept on ice. Immediately following
dissection of all embryos, pancreas RNA was isolated using the
RNeasy® Mini Kit (QIAGEN). Quantitative PCR was carried out in
two steps. First, pancreatic cDNA was synthesized using a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems), fol-
lowed by quantitative RT PCR utilizing the TaqMan® Gene Expression
Fig. 1. Generation of Pax6ΔPE/ΔPE and Pax6ΔDP/ΔDP enhancer knockouts. (A) A 450 bp and a 3.1 kb Pax6 genomic sequence were deleted by gene targeting in Pax6ΔPE and Pax6ΔDP,
respectively. Frt and LoxP sites are represented by open arrows and solid triangles. PE, the Pax6 promoter-proximal enhancer; EE, the ectodermal enhancer; DE, the promoter-
distal enhancer; Sh, Sph I; Sp, Spe I. (B) Southern blots using the 5′ Sph I or the 3′ Spe I probes conﬁrmed the Pax6Neo allele in the ES cell lysates and the Pax6ΔPE and Pax6ΔDP alleles
in mouse tail extracts. (C) Genotyping conﬁrmation of the Pax6ΔPE and Pax6ΔDP mice.
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ment (Applied Biosystems). Primers and probe used for ampliﬁcation of
Pax6 cDNA are: Pax6 F: 5′-CTACCAGCCAATCCCACAGC-3′, Pax6 R: 5′-
TTCGGCCCAACATGGAAC-3′ and probe 5′-(6-FAM)CACCACACCTGTCT-
CCTCCTTCACATCA-3′ (Zhang et al., 2002). The β-actin gene served as
the internal control and its primers included: Actb F: 5′-GGC
TCCTAGCACCATGAA-3′, Actb R: 5′-ACCGATCCACACAGAGTACT and
probe 5′-(6-FAM)TCAAGATCATTGCTCCTCCTGAGCGC. Pax6 gene
expression in the Pax6ΔPE/ΔPE and Pax6ΔDP/ΔDP pancreata normalized to
the internal control Actb, relative to Pax6 expression in the wild type
pancreas was analyzed with StepOne™Software (Applied Biosystems)
using the 2−ΔΔCT method. Experiments were repeated three times,
each in triplicate.
Immunohistochemistry
Fluorescence immunohistochemical analysis of cryo- and parafﬁn
sections were performed as previously described (Carbe and Zhang,2011; Qu et al., 2011a). For immunohistochemistry of pancreatic hor-
mones, E15 embryos were parafﬁn embedded and sectioned trans-
versely to collect all adjacent pancreas sections. Following
deparafﬁnation, antigen unmasking and blocking, pancreatic parafﬁn
sections were incubated with both rabbit polyclonal anti-glucagon
(1:500) (BioGenex, Sam Ramon, CA) and guinea pig anti-human insu-
lin (1:1000) (Linco, St Charles, MO). Immunoﬂuorescent images of
sections were captured and processed with a SPOT RT KE color cam-
era and accompanying SPOT software (Diagnostic Instruments) on a
Leica DM500 compound microscope. Embryonic eye cryo-sections
underwent antigen retrieval and were processed for ﬂuorescence im-
munohistochemistry using mouse monoclonal anti-Pax6 (1:10) (the
Developmental Studies Hybridoma Bank, Iowa City, Iowa), rabbit
polyclonal anti-Pax6 (1:250) and anti-Prox1(1:500), (both from Cov-
ance, Berkeley, California); and anti-α, and β crystallins (1:1000),
both kindly provided by Sam Zigler (National Eye Institute, Bethesda,
MD). Anti-secondary antibodies for all experiments were either Alexa
Fluor-488 (1:250) or Alexa Fluor-555 (1:500) conjugated anti-mouse
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least three embryos were tested for each genotype.Histology
Histology of embryonic eye sections was performed as previously
reported (Pan et al., 2010). Brieﬂy, parafﬁn sections were melted, and
deparafﬁnized in 3 changes of xylene followed by rehydration in ab-
solute ethanol, 95% ethanol and ﬁnally 70% ethanol prior to water
wash and staining in Harris hematoxylin (Fisher Scientiﬁc). Sections
were then washed in running tap water followed by counterstaining
in Eosin Y (Fisher Scientiﬁc), followed by ethanol dehydration and xy-
lene clearing. Following slide mounting in a xylene based medium
(Fisher Scientiﬁc) and drying, eye and lacrimal gland sections were
photographed and processed with a SPOT RT KE color camera, and ac-
companying SPOT software (Diagnostic Instruments) on a Leica
DM500 compound microscope. The lens size was quantiﬁed by the
ImageJ program (National Institute of Health) and the statistical sig-
niﬁcance was calculated using Student's t test.RNA in situ hybridization
RNA in situ hybridization for whole-mount embryos was per-
formed as previously described (Pan et al., 2006). The Pax6 antisense
probe was generated from Pax6 cDNA. Embryos were photographed
with a Leica DFC400 camera mounted on a Leica M165FC dissecting
microscope. At least three embryos were tested for each genotype.Fig. 2. Pax6ΔPE mutation disrupted Pax6 and hormonal expressions in the pancreas. (A) qPC
Pax6ΔPE/ΔPE and Pax6ΔDP/ΔDP pancreata. (B and C) The percentages of insulin and glucagon p
was no statistically signiﬁcant difference between Pax6ΔPE/ΔPE and Pax6ΔDP/ΔDP mutants.Western blot
E14 embryos were snap frozen in 1.5 mL test tubes in liquid nitro-
gen. Ice cold RIPA was then added to the test tube and embryos were
quickly chopped with ice cold scissors before homogenized for 1 min.
Samples were placed on ice for 10 min and then centrifuged at
13,200 rpm for 20 min at 4 °C. Protein concentrations were deter-
mined using a BCA Protein Assay Kit (Pierce). Protein bands were sep-
arated using an SDS-polyacrylamide gel and transferred to a PVDF
membrane (Millipore). After blocking (Licor), the membrane was
submerged in the Prep1 antibody (Santa Cruz #6245, 1:200 in 5%
BSA) overnight at 4 °C and a secondary ﬂuorescent antibody for 2 h
at room temperature. Protein bands were then scanned using a
Licor Odyssey.Data analysis
Immunoﬂuorescent hormone positive area was quantiﬁed as a
proportion of pancreatic epithelial area. In our study every 10th sec-
tion of E15.5 pancreas was immunostained as described above in
Materials and methods with anti-insulin and anti-glucagon followed
by counting the total number of insulin+ and glucagon+ cells per im-
munostained section. Next the area of each hormone-analyzed pan-
creatic epithelial section was measured using ImageJ software
(National Institutes of Health, Bethesda, Maryland). The proportion
of glucagon+ cells and insulin+ cells per epithelial area was
expressed as the number of hormone-positive cells/pancreas section
area. Differences among groups were determined using the unpairedR analysis showed that Pax6 expression was downregulated to a similar extent in the
roducing cells were both reduced in the Pax6ΔPE/ΔPE and Pax6ΔDP/ΔDP pancreata. There
Fig. 3. Lack of ocular phenotype in Pax6ΔPE/ΔPE mutant. (A–F) At E14.5, Pax6ΔPE/ΔPE mutant displayed normal eye morphology, lens histology and lacrimal gland budding. le, lens; lg,
lacrimal gland. (G–L) Pax6, Prox1 and α crystallin expression was unaffected in the Pax6ΔPE/ΔPE mutant lens. (M–P) The adult Pax6ΔPE/ΔPE mutant at P21 has normal eye size and
clear lens.
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least three samples were used for each genotype.
Results
The 450 bp proximal enhancer (PE) is required for the Pax6 pancreatic
expression
To determine the functional signiﬁcance of the three known en-
hancers upstream to the Pax6 P0 promoter, we constructed two
strains of knockout mice. In Pax6ΔPE, the 450 bp promoter-proximal
enhancer (PE) was deleted from the mouse genome by homologous
recombination (Fig. 1A). This is followed by a Cre-mediate recombi-
nation to remove a 3.1 kb sequence in Pax6ΔDP mice, which further
deleted both the promoter-distal enhancer (DE) and the ectodermal
enhancer (EE). By Southern blots, we veriﬁed the correct targeting
of Pax6 locus in ES cells, and demonstrated the progressive deletion
of the three enhancer elements in the Pax6ΔPE and Pax6ΔDP mice
(Figs. 1B and C). Monitored by genotyping PCR (Fig. 1D), we back-
crossed these mice to the C57BL/6 strain for six generations to ensure
a uniform genetic background.
Quantitative real time RT-PCR in the E15.5 Pax6ΔPE/ΔPE pancreas,
null for the 450 bp PE element, show a 36.5% decrease in Pax6 expres-
sion compared to wild type (P=0.0016) (Fig. 2A). This is similar to
the 40% decrease in Pax6 expression in the E15.5 Pax6ΔDP/ΔDP pancre-
as, which is null for both the PE and DE elements (Pb0.0001)
(Fig. 2A). Thus, deletion of the DE element did not further disrupt
the Pax6 pancreatic expression. Since Pax6 is a key regulator of pan-
creatic islet development, we next examined the number of α and
β cells by ﬂuorescent immunohistochemistry. For the glucagon-
producing α cells, the Pax6ΔPE/ΔPE mutants showed a 39.4%(P=0.0009) reduction compared to the wild type, while the
Pax6ΔDP/ΔDP mutants showed a 47.8% (P=0.0022) loss (Figs. 2B and
C). Similarly, the insulin-producing β cells were reduced by 44.1% in
the Pax6ΔPE/ΔPE mutants and 30.4% in the Pax6ΔDP/ΔDP mutants. The
differences of α and β cell numbers between mutants, however,
were not signiﬁcant. Taken together, these results demonstrate that
the PE enhancer is necessary for the full Pax6 expression in pancreas.
On the other hand, deletion of the putative distal enhancer DE failed
to enhance the PE-deletion phenotype, suggesting that the DE en-
hancer does not play a signiﬁcant role in regulating the Pax6 pancre-
atic transcription.
Combined deletion of PE, EE and DE downregulated Pax6 expression in
the lens and the lacrimal gland
We next examined eye development in the Pax6ΔPE/ΔPE mutants.
At E14.5, the Pax6ΔPE/ΔPE embryos appeared grossly normal, without
any reduction in both lens and lacrimal gland sizes (Figs. 3A–F). Con-
sistent with this, Pax6 immunostaining was also unchanged in the
lens, retina and surface ectoderm (Figs. 3G and H). Prox1 is homeo-
box transcription factor required for lens ﬁber elongation and α crys-
tallin is a lens terminal differentiation marker. Similar levels of Prox1
and α crystallin expression were also observed in the Pax6ΔPE/ΔPE and
wild type lens (Figs. 3I–L). Finally, the postnatal day 21 (P21) Pax6ΔPE/
ΔPE animals have similarly sized eyeballs as the wild type controls and
their lenses did not exhibit any cataracts (Figs. 3M–P). Therefore, de-
letion of the PE element alone did not affect eye development.
In contrast to the normal appearance of the Pax6ΔPE/ΔPE mutant
eyes, the Pax6ΔDP/ΔDP mutants exhibit signiﬁcant ocular defects. At
E14.5, the Pax6ΔDP/ΔDP mutant eye was already conspicuously smaller
than the wild type controls and the retinal pigmented epithelium of
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B, arrows). Histological analysis of this mutant further revealed a hy-
poplastic lens, with the posterior lens ﬁber failing to rise up to the an-
terior lens epithelium. Importantly, the Pax6ΔDP/ΔDP mutant lens
remained attached to the overlying surface ectoderm, which resem-
bled the Peter's anomaly phenotype in human (Figs. 4C and D, ar-
rows). Pax6 expression in the conjunctival epithelium is also known
to be required for normal lacrimal gland budding (Makarenkova et
al., 2000). As expected, the Pax6ΔPE/ΔPE lacrimal gland was consider-
ably shorter in length than that of the wild type (Figs. 4E and F, ar-
rows). It has also been previously reported that the deletion of the
EE element alone disrupted Pax6 expression in early lens develop-
ment, but it led to only moderate reduction in lens size at E17.5
(Dimanlig et al., 2001). In contrast, the Pax6ΔDP/ΔDP lens was not only
signiﬁcantly smaller than the wild type at E14.5, but also completely
degenerated by P6, leaving behind a disorganized neural retina
(Figs. 4G–I). Therefore, the Pax6ΔDP/ΔDP mutant exhibited much more
severe ocular defects than the deletion of EE element alone.
Expression analysis further conﬁrmed that Pax6was indeed down-
regulated in the Pax6ΔDP/ΔDPmutants. At E10.5 when lens developmentFig. 4. Defective lens and lacrimal gland development in Pax6ΔDP/ΔDP mutants. (A and
B) The E14.5 Pax6ΔDP/ΔDP mutant exhibited coloboma, due to a failure of optic cup clo-
sure (arrows). (C and D) Compared to the wild type, the Pax6ΔDP/ΔDP mutant lens was
much reduced in size and remained attached to the surface ectoderm (arrows). (E and
F) The lacrimal gland budding was stunted in Pax6ΔDP/ΔDP mutant. (G and H) By P6, the
lens completely degenerated in Pax6ΔDP/ΔDP mutant. (I) Quantiﬁcation of lens size at
E14.5. [Student's t test: Pb0.0001 for the Pax6ΔDP/ΔDP mutants (n=4) compared to
the wild type (n=6).]was initiated, whole mount RNA in situ hybridization with a Pax6 anti-
sense RNA probe revealed a striking reduction in Pax6 expressionwith-
in the Pax6ΔDP/ΔDP lens vesicle compared to the wild type (Figs. 4A–D,
dotted circles). In contrast, optic vesicle Pax6 expression remained
unchanged (Figs. 4A–D, arrows). Similarly, Pax6 protein expression as
shown by immunostaining was clearly diminished in the Pax6ΔDP/ΔDP
mutant lens at E14.5 (Figs. 5E and F, arrows). This was in contrast
with the previously reported deletion of the EE element, which affected
Pax6 expression only at E9.5 but not at E13.5 and later stages (Dimanlig
et al., 2001). Consistentwith the persistent corneal–lenticular adhesion,
Prox1 was also downregulated in the central lens epithelium (Figs. 5G
and H, arrows). The rest of the lens, however, still exhibited normal ex-
pression pattern of Prox1, α and β crystallins (Figs. 5G–L). This agrees
with a recent report that conditional knockout of Pax6 at this stage
does not affect Prox1 and crystallins expressions (Shaham et al.,
2009). Taken together, these results suggest that the Pax6ΔDP/ΔDP mu-
tant has deleted additional enhancer(s) that cooperate with the EE ele-
ment in regulating Pax6 lens expression.
Conditional knockout of Prep1 did not affect Pax6 lens and pancreatic
expression
Previous studies have showed that, at least in vitro, the Meis/Prep
family homeodomain proteins can bind to all three DE, EE and PE el-
ements (Delporte et al., 2008; Rowan et al., 2010; Zhang et al., 2002,
2006). This suggests that the cooperative binding of these elements to
Meis/Prep proteins may underlie the synergistic interactions among
these elements. In agreement with this, the crossing of a Prep1 hypo-
morphic allele and a null allele was recently shown to disrupt lens in-
duction but not pancreatic development, supporting a dose-
dependent role of Prep1 in lens Pax6 regulation (Rowan et al.,
2010). To further test this model, we sought to generate a conditional
knockout of Prep1 to investigate whether Pax6 is regulated cell auton-
omously by Prep1 in lens development.
To generate the Prep1ﬂox allele, we employed the standard gene
targeting techniques to insert two loxP sites and an frt-ﬂanked Neo se-
lection cassette into the Prep1 locus, which was conﬁrmed by South-
ern blots (Figs. 6A and B). The Neo gene was subsequently removed
via FLP-mediated recombination in germ line, leaving behind only
two loxP sites and an frt site next to the exon 8 of the Prep1 gene.
The resulting Prep1ﬂox allele was further crossed with a ubiquitous
Cre-expressing strain (EIIa-Cre) to generate the Prep1Δ allele, which
was conﬁrmed to have lost the Prep1 exon 8 by genotyping PCR
(Fig. 6C). Consistent with this, Western blots using a Prep1 antibody
revealed a 59 kDa truncated protein in addition to the 64 kDa wild
type protein in the Prep1Δ/+ lysates (Fig. 6D). The Prep1 exon 8 en-
codes the N-terminal portion of the homeodomain, which is critical
for Prep1 DNA binding activity. As expected, no homozygous E12.5
Prep1Δ/Δ mutants were ever uncovered in the Prep1Δ/+ heterozygous
intercrosses (Fig. 6E), which agrees with the previous report that the
Prep1 null embryos died in utero soon after implantation (Fernandez-
Diaz et al., 2010).
We ﬁrst ablated Prep1 during early lens development using the
Ap2α-Cre driver, which was generated by inserting a Cre cDNA se-
quence into the endogenous Ap2α locus (Macatee et al., 2003). Previ-
ous studies have shown that Ap2α-Cre begins to express Cre
recombinase in the presumptive lens ectoderm at E8.0, preceding
the onset of Pax6 expression at E8.5 (Grindley et al., 1995; Song et
al., 2007). Interestingly, the E10.5 Ap2α-Cre;Prep1ﬂox/ﬂox embryos
exhibited normal lens vesicle invagination, and their Pax6 expression
was also indistinguishable from that of the wild type (Figs. 7A and B).
To further conﬁrm this ﬁnding, we next employed a widely used lens
and pancreatic Cre driver, Le-Cre transgene, which is controlled by a
6.5 kb Pax6 promoter fragment that contains the DE, EE and PE ele-
ments (Ashery-Padan et al., 2000). Active as early as E9.5, this Cre
deletor line has been previously used to generate a conditional
Fig. 5. Pax6ΔDPmutation disrupted Pax6 lens expression. (A–D)Wholemount RNA in situ hybridization showed that Pax6 expressionwas speciﬁcally reduced in the E10.5 Pax6ΔDP/ΔDP lens
vesicle (dotted circles). ov, optic vesicle; lv, lens vesicle. (E and F) Pax6 protein expression was also reduced in the E14.5 Pax6ΔDP/ΔDP mutant lens (arrows). (G–L) Prox1 expressed was
downregulated in the anterior lens epithelium which was attached to the surface ectoderm (arrows), whereas α and β crystallins were still expressed.
326 C. Carbe et al. / Developmental Biology 363 (2012) 320–329knockout of Pax6 in lens and pancreas progenitor cells, resulting in a
complete abrogation of lens formation and early postnatal lethality
due to defective β cell function (Ashery-Padan et al., 2000, 2004).
Therefore, the Le-Cre transgene is an effective Cre drive to test the
maintenance of Pax6 expression, which is required for lens and pan-
creatic maturation. Le-Cre also contains a bicistronic GFP reporter,
which can be used to monitor the enhancer activity of the 6.5 kb
Pax6 genomic fragment that includes the DE, EE and PE elements
(Pan et al., 2008). At E14.5, identical GFP expression was again ob-
served in the Le-Cre and Le-Cre;Prep1ﬂox/ﬂox cornea, lens and lacrimal
gland buds (Figs. 7C and D). Consistent with this, the Le-Cre;Pre-
p1ﬂox/ﬂox did not exhibit any changes in Pax6 and α crystallin immu-
nostaining at E14.5 or histological abnormality at E16.5 (Figs. 7E–J).
Furthermore, the adult Le-Cre;Prep1ﬂox/ﬂox mice were also healthy
and fertile, without any overt endocrine phenotype. Indeed, quantita-
tive real time RT-PCR conﬁrmed that Pax6 was expressed at the same
level in both the wild type and Le-Cre;Prep1ﬂox/ﬂox E15.5 pancreata
(Fig. 7K). Therefore, Prep1 ablation failed to disrupt Pax6 regulation
in pancreatic and lens development.
Discussion
To date, the precise location of the Pax6 pancreatic enhancer re-
mains controversial. In their thorough molecular dissection of the
regulatory elements within the murine Pax6 locus, Kammandel et al.
(1999) observed pancreatic expression from transgenic reporter con-
structs that contained a 5 kb Pax6 genomic fragment, but not a 3 kb
sub-fragment. This ﬁnding prompted them to attribute the Pax6
pancreatic enhancer to a 124 bp highly conserved sequence
(referred to as DE in this study) in the truncated region, located at
3.3 kb upstream of the Pax6 P0 promoter. The in vivo activity of this
conserved sequence, however, has never been tested in transgenic
analysis by itself. Instead, we have provided evidence that a 450 bp
nucleotide conserved sequence (referred to as PE in this study)
located approximately 1.9 kb upstream from the Pax6 P0 promoter
can independently drive reporter expression in the developing
murine pancreas (Zhang et al., 2003, 2006). More recently, it was
observed that the zebraﬁsh pax6b gene, which harbors both the DEand PE elements, is expressed in pancreas (Delporte et al., 2008;
Kleinjan et al., 2008). In contrast, the other Pax6 paralog in zebraﬁsh,
pax6a, which does not have the DE element, has concomitantly lost
its pancreatic expression. This apparent correlation between the
zebraﬁsh pax6 DE sequence and pancreatic activity was further
supported by promoter exchange experiments, which showed that
the PE-containing pax6a promoter can be activated in the pancreas
when fused with the pax6b DE element (Kleinjan et al., 2008). Never-
theless, this result was recently challenged by further transgenic ana-
lyses performed by Delporte et al. (2008), who showed that the
pax6b PE element, but not DE element, can drive a heterologous pro-
moter in the pancreas, although the overall expression level is much
lower than that achieved by combining the PE and DE sequences. It
was therefore proposed that the Pax6 PE element is responsible for
the pancreatic speciﬁc expression, while the Pax6 DE element is neces-
sary for maintaining a high level of expression.
It is unclear what causes the above discrepancies in locating the
Pax6 pancreatic enhancer. While the differences in the species and
experimental designs could certainly play a role, it is also clear that
these studies were all susceptible to random transgenic insertion
events, which was known to negatively affect the consistency of any
transient transgenic analysis. In fact, although transgenic analysis is
a powerful in vivo tool for expression studies, it nevertheless takes
an enhancer out of its larger genomic context. This is especially prob-
lematic for investigating the mammalian Pax6 regulation, because ad-
ditional regulatory elements, such as locus control regions, have been
identiﬁed hundreds of kb away from the Pax6 promoter region
(Kleinjan et al., 2001; Lauderdale et al., 2000). Therefore, we have
employed the genomic deletion approach in this study to examine
the functional signiﬁcance of the previously reported murine pancre-
atic enhancer regions. We showed that the removal of the 450 bp PE
element alone signiﬁcantly reduced, but did not abolish, pancreatic
Pax6 expression and hormonal production, suggesting that there ex-
ists additional pancreatic enhancer(s) in the Pax6 locus. Nevertheless,
a larger genomic deletion that encompassed both the DE and PE ele-
ments failed to cause additional Pax6 reduction or pancreatic defects.
These results underlie the importance of the genomic deletion ap-
proach as a functional test of transcriptional regulatory elements,
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the upstream DE element, is necessary for the full Pax6 expression in
murine pancreatic cells.
Our enhancer-knockout experiments further revealed the complex-
ity of the Pax6 ocular regulation. Whereas targeted elimination of the
450 bp PE element in our Pax6ΔPE/ΔPEmutants appeared to have no del-
eterious effect on eye development, combined deletion of DE, EE and PE
sequences in the Pax6ΔDP/ΔDP embryos resulted in optic colobomas and a
hypoplastic lens that failed to separate from the surface ectoderm.
Clearly these phenotypes are reminiscent of the Pax6ΔEE/ΔEE mutants
(lens hypoplasia and failure of lens detachment), which targeted the
EE element, and the Pax6sey (small eye) heterozygous nulls (lens defects
and optic colobomas) (Dimanlig et al., 2001; Hill et al., 1991). However,
the lens defects in the Pax6ΔDP/ΔDP embryos also appeared to be moreFig. 6. Generation of Prep1ﬂox allele. (A) Through homologous recombination, two loxP sites
quent deletion of exon 8 via Cre-mediated recombination to generate the Prep1Δ allele. The
Conﬁrmation of the gene targeting in ES cells by Southern blots using the 5′ and 3′ probes. (C
the truncated protein in the Prep1Δ/+ mutant mice. (E) No E12.5 Prep1Δ/Δ mutants were resevere than that of the Pax6ΔEE/ΔEE mutants. For example, although the
Pax6ΔEE/ΔEE mutants exhibited distinct defects in early lens develop-
ment, its Pax6 expression and lens size became largely normal during
late gestation (Dimanlig et al., 2001). In contrast, the Pax6ΔDPmutation
led to signiﬁcant reduction in lens Pax6 expression at E14.5, and com-
plete lens degeneration after birth. Based on distinct lens phenotype
in the Pax6ΔEE/ΔEE mutants, Dimanlig et al. have proposed that there
are two phases of Pax6 expressions in lens development, one pre-
placodal and one placodal. Here, the severe lens defects in our
Pax6ΔDP/ΔDP embryos suggest another post-placodal phase of Pax6 ex-
pression, which must be separately regulated from the earlier two
phases to support the late-stage lens development. Since Pax6 expres-
sion was diminished, but not eliminated, in the Pax6ΔDP/ΔDP lens, en-
hancers outside the 3.1 kb deletion region are still important for thesewere inserted next to the Prep1 exon 8 to create the Prep1ﬂox allele. This allows subse-
shaded boxes in exons 8–10 code for the Prep1 homoedomain. K, Kpn I; Ev, EcoRV. (B)
) Genotyping conﬁrmation of the Prep1ﬂox and Prep1Δmice. (D) Western blots showed
covered in heterozygous Prep1Δ/+ mating.
Fig. 7. Prep1 conditional knockout failed to disrupt lens and pancreas development. (A and B) Ap2α-Cremediated Prep1 knockout did not affect lens induction and Pax6 expression.
lv, lens vesicle. (C and D) Eye and lacrimal gland morphology as represented by the GFP expression from the Le-Cre transgene was normal in the Le-Cre;Prep1ﬂox mutant. co, cornea;
le, lens; lg, lacrimal gland. (E–J) The Prep1 conditional knockout did not affect Pax6 and α crystallin expression and lens histology. (K) Pax6 expression measured by qPCR was
unchanged in the E15.5 Le-Cre;Prep1ﬂox mutant pancreas.
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speculate that DE, EE and/or PE elements, the only sequences within
the 3.1 kb that are evolutionarily conserved throughout vertebrates,
may synergistically act to establish the precise control of the Pax6
late-stage lens expression.
Despite their general lack of sequence similarity, the DE, EE and PE
elements are all capable of binding to the Meis/Prep family homeodo-
main proteins in vitro (Delporte et al., 2008; Rowan et al., 2010;
Zhang et al., 2002, 2006). This striking commonality suggests that
Meis/Prep proteins may be conserved upstream regulators of Pax6
in both lens and pancreas development. To test this model, we gener-
ated conditional knockouts of Prep1 using the Ap2α-Cre and Le-Cre
transgenes, targeting the pre-placodal and placodal phases of lens in-
duction, respectively (Ashery-Padan et al., 2000; Macatee et al., 2003;
Song et al., 2007). To our surprise, neither Prep1 conditional mutants
displayed any lens or pancreatic defects or Pax6 expression changes.
Rowan et al. (2010) recently showed that a compound Prep1 mutant
carrying one hypomorphic allele and one null allele also failed to
disrupt pancreatic Pax6 expression, but this mutant nevertheless
showed signiﬁcant lens induction defects. One possible explanation
for the discrepancy is that Prep1 was systemically disrupted through-
out the compound Prep1 mutant, whose lens defects may thus be an
indirect consequence of multiple tissue defects. Such a phenomenon
is not without precedence for a transcription factor, as the lens specif-
ic deletion of Ap2α also failed to recapitulate the lens induction de-
fects observed in the germ-line Ap2α knockout (Pontoriero et al.,
2008). Furthermore, there are ﬁve members of the Meis/Prep family
protein expressed in overlapping patterns in the lens and pancreas.
Since they recognize the same consensus DNA binding site, it is con-
ceivable that the genetic redundancy within the Meis/Prep familymay obscure the function of Prep1 in later lens and pancreas develop-
ment. Finally, even though Cre-mediated conditional knockouts may
exhibit a delay in protein loss after the initial gene deletion (Pan et
al., 2010; Qu et al., 2011b), the complete lack of lens defect in our
two Prep1mutants demonstrates that Prep1 alone is at least dispens-
able for the maintenance of Pax6 expression in lens and pancreatic
development.
In summary, we have used gene targeting technology to conclu-
sively demonstrate the importance of three upstream enhancers in
Pax6 lens and pancreas regulation. To date, the molecular diagnosis
of human aniridia patients have primarily depended on the scrutiny
of PAX6 exon mutations. Our study of these Pax6 regulatory se-
quences may help to guide the search for Pax6 functional mutations
into the much wider non-coding regions. We also showed that a con-
ditional knockout of Prep1 failed to disrupt Pax6 expression in lens
and pancreatic development, raising the question of Prep1 tissue au-
tonomy in lens induction and/or redundancy in Meis/Prep gene func-
tions. Further studies should focus on the combined deletion of
multiple Meis/Prep genes to study their roles in lens and pancreas
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